Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Pyxis Oncology, Inc.
13G/A
Amendment 3
PYXS · 747324101
|
16.4% |
10/9/2026
Event 10/1/2026
|
|||
| GordonMD Global Investments LP | 16.4% | ||||
| GordonMD Long Biased Master Fund LP | 16.4% | ||||
| GordonMD Long Biased GP LLC | 16.4% | ||||
| Craig D. Gordon | 16.4% | ||||
|
Pyxis Oncology, Inc.
13G/A
Amendment 2
PYXS · 747324101
|
17.5% |
10/2/2026
Event 10/1/2026
|
|||
| GordonMD Global Investments LP | 17.5% | ||||
| GordonMD Long Biased Master Fund LP | 17.5% | ||||
| GordonMD Long Biased GP LLC | 17.5% | ||||
| Craig D. Gordon | 17.5% | ||||
|
Pyxis Oncology, Inc.
13G/A
Amendment 1
PYXS · 747324101
|
12.1% |
7/2/2026
Event 6/30/2026
|
|||
| GordonMD Global Investments LP | 12.1% | ||||
| GordonMD Long Biased Master Fund LP | 12.1% | ||||
| GordonMD Long Biased GP LLC | 12.1% | ||||
| Craig D. Gordon | 12.1% | ||||
|
Kyverna Therapeutics, Inc.
13G
KYTX · 501976104
|
7.0% |
11/17/2025
Event 11/13/2025
|
|||
| GordonMD Global Investments LP | 7.0% | ||||
| GordonMD Long Biased Master Fund LP | 6.2% | ||||
| GordonMD Long Biased GP LLC | 6.2% | ||||
| Craig D. Gordon | 7.0% | ||||
| GordonMD Global Investments GP LLC | 7.0% | ||||
|
Pyxis Oncology, Inc.
13G
PYXS · 747324101
|
6.2% |
9/23/2025
Event 7/14/2025
|
|||
| GordonMD Global Investments LP | 6.2% | ||||
| GordonMD Long Biased Master Fund LP | 6.2% | ||||
| GordonMD Long Biased GP LLC | 6.2% | ||||
| Craig D. Gordon | 6.2% | ||||